Back to Results
First PageMeta Content
Clinical research / Medicinal chemistry / New chemical entity / Food and Drug Administration / Active ingredient / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry


Microsoft Word - Post Hearing Brief
Add to Reading List

Document Date: 2015-05-28 14:28:40


Open Document

File Size: 30,12 KB

Share Result on Facebook

Company

See Actavis Elizabeth LLC / Abbott Labs. / Actavis Elizabeth LLC / Chevron / OF COLUMBIA AMARIN PHARMACEUTICALS LTD. / /

/

Event

FDA Phase / /

Facility

RESPONSE TO THE COURT / /

IndustryTerm

fixed-dose combination products / drug product / chemical compounds / chemical entity / chemical type / drug products / /

Organization

Congress / HHS office of the General / FOOD AND DRUG ADMINISTRATION / U.S. Department of Justice / Court of Appeals / /s/ Ann F. Entwistle ANN F. ENTWISTLE Trial Attorney Consumer Protection Branch Civil Division U.S. Department / UN Court / US Federal Reserve / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA AMARIN PHARMACEUTICALS IRELAND LTD. / Litigation U.S. Department / FDA Exclusivity Board / Environmental Protection Agency / B. SCHULTZ General Counsel BENJAMIN C. MIZER Acting Assistant Attorney General ELIZABETH H. DICKINSON Associate General Counsel / Food and Drug Division / /

Person

WILLIAM B. SCHULTZ / ELIZABETH H. DICKINSON / Waxman / BENJAMIN C. MIZER / ANNAMARIE KEMPIC / SHOSHANA HUTCHINSON / MICHAEL S. BLUME / /

/

Position

Counsel / Deputy Chief Counsel / Director / Associate Chief Counsel / Representative / /

Product

Lovaza / menotropins / podofilox / EPA / court / /

ProvinceOrState

Columbia Circuit / /

SocialTag